Your email has been successfully added to our mailing list.

×
-0.00718346253229975 0 0 0 0.00516795865633075 0.00160206718346259 -0.0180878552971576 -0.0155038759689921
Stock impact report

Nkarta to Participate in March Investor Conferences [Yahoo! Finance]

Nkarta, Inc. (NKTX) 
Company Research Source: Yahoo! Finance
engineered natural killer (NK) cell therapies, today announced its participation in the following investor conferences: TD Cowen 45 th Annual Health Care Conference March 3, 2025 3:10 p.m. ET – fireside chat Leerink Partners 2025 Global Healthcare Conference March 10, 2025 3:00 p.m. ET – fireside chat A simultaneous webcast of the events will be available on the Investors section of Nkarta's website, www.nkartatx.com , and a replay will be archived on the website for approximately 90 days. About Nkarta Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary Read more
Impact Snapshot
Event Time:
NKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Created with Highstock 5.0.1230sec1m5m10m30m60m90m120m-2.00%-1.00%0.00%1.00%
Opt-in for NKTX alerts
Opt-in for
NKTX alerts

from News Quantified
Opt-in for
NKTX alerts

from News Quantified